The Bio Report

563 Episodes

1. The Havoc-Wreaking Zombies Lurking in Life Sciences Boardrooms

   Published: 3/17/2016
2. New FDA Chief Faces Challenges

   Published: 3/10/2016
3. Seeking a Best-in-Class Antibody at Bargain Basement Prices

   Published: 3/3/2016
4. Pharma Bro, Price Controls, and the Quest to Balance Innovation with Affordability

   Published: 2/25/2016
5. California’s Stem Cell Agency Plots Its Future

   Published: 2/18/2016
6. ViaCyte Pursues ”Functional Cure” for Type 1 Diabetes

   Published: 2/11/2016
7. Building a Better Pain Pill

   Published: 2/4/2016
8. Project GENIE Hopes to Make Precision Medicine a Reality

   Published: 1/28/2016
9. FDA Wants Industry to Guard Against Cybersecurity Risks of Medical Devices

   Published: 1/21/2016
10. Pharma’s Leadership Vacuum and Its Price to the Industry

    Published: 1/14/2016
11. Permanent R&D Tax Credit a Boost to Life Sciences

    Published: 1/7/2016
12. Biotech in 2015 and the Year Ahead with TheStreet’s Adam Feuerstein

    Published: 12/31/2015
13. Trends Shaping the New Health Economy in 2016

    Published: 12/24/2015
14. Declining R&D Productivity Continues to Plague Big Pharma

    Published: 12/17/2015
15. Searching for Solutions to Rising Specialty Drug Prices

    Published: 12/10/2015
16. Biohackers Seek a Faster, Cheaper Path to Insulin

    Published: 12/3/2015
17. A Scorecard to Improve Drugmakers’ Transparency

    Published: 11/25/2015
18. Forget the Chemistry Set, Mom, I Want a Bioreactor

    Published: 11/19/2015
19. Ensuring Biological Tools Benefit the Environment

    Published: 11/13/2015
20. New SEC Rules Open Crowdfunding to the Masses

    Published: 11/5/2015